Antisense oligonucleotides: modifications and clinical trials

VK Sharma, RK Sharma, SK Singh - MedChemComm, 2014 - pubs.rsc.org
There has been an upsurge in the number of clinical trials involving chemically modified
oligonucleotide-based drug candidates after the FDA approval of Vitravene, Macugen, and …
被引用次数：229 相关文章

[引用][C] Antisense oligonucleotides: modifications and clinical trials

VK Sharma, RK Sharma, SK Singh - Med. Chem. Commun., 2014 - cir.nii.ac.jp
Antisense oligonucleotides: modifications and clinical trials | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF] academia.edu

[PDF][PDF] Antisense oligonucleotides: modifications and clinical trials

VK Sharma, RK Sharmab, SK Singh - academia.edu
There has been an upsurge in the number of clinical trials involving chemically modified
oligonucleotidebased drug candidates after the FDA approval of Vitravene, Macugen, and …